TSS (NASDAQ:TSSI - Get Free Report) announced its earnings results on Thursday. The company reported $0.08 EPS for the quarter, Zacks reports. TSS had a net margin of 3.59% and a return on equity of 87.89%. The business had revenue of $50.03 million during the quarter.
TSS Stock Down 4.8 %
Shares of NASDAQ TSSI traded down $0.40 during trading hours on Monday, hitting $7.85. 1,792,949 shares of the stock were exchanged, compared to its average volume of 1,199,811. TSS has a 12 month low of $0.48 and a 12 month high of $18.26. The firm has a fifty day moving average price of $11.92 and a 200-day moving average price of $9.88. The company has a market cap of $187.45 million, a PE ratio of 43.61 and a beta of 0.79.
Hedge Funds Weigh In On TSS
An institutional investor recently bought a new position in TSS stock. Bank of America Corp DE acquired a new position in TSS, Inc. (NASDAQ:TSSI - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 3,377 shares of the company's stock, valued at approximately $40,000.
About TSS
(
Get Free Report)
TSS, Inc offers planning, design, engineering, construction management, commissioning and maintenance services. It provides these services primarily for specialized facilities such as data centers, communications rooms, call centers, laboratories, trading floors, network operations centers, medical facilities and similar environments.
Featured Articles
Before you consider TSS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TSS wasn't on the list.
While TSS currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
